These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 18070122

  • 81. Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears.
    Krishnamurthy S, Dimashkieh H, Patel S, Sneige N.
    Diagn Cytopathol; 2003 Dec; 29(6):309-14. PubMed ID: 14648786
    [Abstract] [Full Text] [Related]

  • 82. Carcinoma of unknown primary: check the liver... thanks to TTF-1.
    Mishra M, Morgan V, Hamati AK, Al-Abbadi M.
    Tenn Med; 2012 Jan; 105(1):35-6, 40. PubMed ID: 22359993
    [Abstract] [Full Text] [Related]

  • 83.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 84.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 85.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 86. Occult hepatocellular carcinoma metastasising to the left temple diagnosed by fine-needle aspiration biopsy.
    Karim RZ, Greenberg ML.
    Diagn Cytopathol; 2006 Jun; 34(6):430-3. PubMed ID: 16680775
    [Abstract] [Full Text] [Related]

  • 87. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
    Kara B, Doran F, Kara IO, Akkiz H, Sandikci M.
    Int J Clin Pract; 2008 Aug; 62(8):1206-11. PubMed ID: 18284441
    [Abstract] [Full Text] [Related]

  • 88. CD10 facilitates the diagnosis of metastatic renal cell carcinoma from primary adrenal cortical neoplasm in adrenal fine-needle aspiration.
    Yang B, Ali SZ, Rosenthal DL.
    Diagn Cytopathol; 2002 Sep; 27(3):149-52. PubMed ID: 12203861
    [Abstract] [Full Text] [Related]

  • 89.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 90.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 91.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 92.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 93. Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions.
    Tátrai P, Somorácz A, Batmunkh E, Schirmacher P, Kiss A, Schaff Z, Nagy P, Kovalszky I.
    Am J Surg Pathol; 2009 Jun; 33(6):874-85. PubMed ID: 19194276
    [Abstract] [Full Text] [Related]

  • 94.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 95. Diagnostic utility of Glut-1 and CA 15-3 in discriminating adenocarcinoma from hepatocellular carcinoma in liver tumors biopsied by fine-needle aspiration.
    Zimmerman RL, Burke M, Young NA, Solomides CC, Bibbo M.
    Cancer; 2002 Feb 25; 96(1):53-7. PubMed ID: 11836704
    [Abstract] [Full Text] [Related]

  • 96.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 97.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 98. Role of glypican-3 immunocytochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver utilizing fine needle aspiration cytology.
    Zaakook M, Ayoub M, Sinna EA, El-Sheikh S.
    J Egypt Natl Canc Inst; 2013 Dec 25; 25(4):173-80. PubMed ID: 24207089
    [Abstract] [Full Text] [Related]

  • 99. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K, Strobel D, Bernatik T, Blank W, Friedrich-Rust M, Herbay Av, Dietrich CF, Strunk H, Kratzer W, Schuler A.
    Ultraschall Med; 2009 Aug 25; 30(4):383-9. PubMed ID: 19688670
    [Abstract] [Full Text] [Related]

  • 100. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S, Mar N, McCalmont TH.
    Am J Surg Pathol; 2008 Aug 25; 32(8):1111-22. PubMed ID: 18545147
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.